The Comeback of Psychedelics for the Treatment of Depression?
Psilocybin, LSD, and DMT as potential anti-depressants
The People's Scientist · Dr. Stephanie Caligiuri
Audio is streamed directly from the publisher (sphinx.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Today in Episode 102, I share some scientific evidence on psychedelics or hallucinogens in the context of mood disorders and mental health. In the 1960s and 1970s, a psychedelic, LSD, was studied for its ability to improve mood in patients diagnosed with a terminal illness. However, regulatory laws stopped this type of research until recently when it was granted a status of Breakthrough Therapy Designation allowing it to be studied in clinical populations again. Are there benefits in depression and anxiety? Tune in to find out!
Want to buy me a coffee to say thanks for the episode? You can do so via Venmo or Patreon below.
Venmo ID: Steph-Cal
Patreon: https://www.patreon.com/join/DrSCaligiuri
Follow me on social media to see the papers I cite in this week's episode:
IG: Dr.SCaligiuri
FB: ThePeoplesScientist
Twitter: DrSCaligiuri
Linkedin: Stephanie Caligiuri
TikTok: Dr.SCaligiuri
Hosted on Acast. See acast.com/privacy for more information.